Thus, pericyte TMEM16A is a crucial regulator of cerebral capillary function and a potential therapeutic target for stroke and possibly other disorders of impaired microvascular flow, such as Alzheimer’s disease and vascular dementia. The gene discussed is ANO1; the disease is early-onset autosomal dominant Alzheimer disease.